key: cord-1012887-chvxngtf
authors: Cioffi, Andrea
title: Perspectives of medical abortion in Italy
date: 2020-08-18
journal: Sex Reprod Healthc
DOI: 10.1016/j.srhc.2020.100550
sha: b0c81ac8fa1bcb9ed36a2e6b5d349b5368d63ed2
doc_id: 1012887
cord_uid: chvxngtf

nan

I recently published an article on the importance of ensuring access to abortion also during the COVID-19 pandemic [1] . The article referred to the fact that many Italian gynaecological associations, have called for greater recourse to medical abortion moving the legal limit for treatment from 7 to 9 weeks of pregnancy and also Therefore, in Italy, on the basis of the problems already analyzed in the reference article [1] , the legal limits of abortion through Mifepristone will change. This procedure, as in other countries of the European Union, will be carried out (in Hospital day care) until the ninth week of pregnancy and will no longer need a hospitalization of 3 days after the administration of the drug. In fact, after 30 minutes of observation, women will be able to return home. Then, after 2 weeks, there will be a follow-up visit [3] .

This change, especially in the COVID-19 emergency phase, is an important milestone to ensure the self-determination of all women. Indeed, even in the presence of conscientious objectors and other health care problems [1] , women will have access to medical abortion with fewer difficulties.

COVID-19 and abortion: The importance of guaranteeing a fundamental right

Aborto con la pillola: non serve il ricovero', cade l'ultimo tabù